Locally, you can enroll to Dr. Ugonma Chukwueke's @ALLIANCE_org trial exploring if adding a targeted medicine called vorasidenib to the usual treatment can help people with newly diagnosed IDH mutated grade 3 astrocytoma, a type of brain cancer. bit.ly/Brain2026